Early Sorafenib-Induced Toxicity Is Associated with Drug Exposure and UGTIA9 Genetic Polymorphism in Patients with Solid Tumors: A Preliminary Study-Reference-Cited by-同舟云学术

Early Sorafenib-Induced Toxicity Is Associated with Drug Exposure and UGTIA9 Genetic Polymorphism in Patients with Solid Tumors: A Preliminary Study

Published:2012-08-13 Issue:8 Volume:7 Page:e42875
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Boudou-Rouquette Pascaline,Narjoz Céline,Golmard Jean Louis,Thomas-Schoemann Audrey,Mir Olivier,Taieb Fabrice,Durand Jean-Philippe,Coriat Romain,Dauphin Alain,Vidal Michel,Tod Michel,Loriot Marie-Anne,Goldwasser François,Blanchet Benoit

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonalcoholic steatohepatitis increases plasma retention of sorafenib-glucuronide in a mouse model by altering hepatocyte hopping;Acta Pharmaceutica Sinica B;2024-09

2. A systematic review and meta‐analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer;Clinical and Translational Science;2024-05

3. Genotype influenced pharmacokinetics of anticancer medicine: A connecting link;Biomarkers in Cancer Detection and Monitoring of Therapeutics;2024

4. Selection of clinically relevant drug concentrations for in vitro studies of candidates drugs for cancer repurposing: a proposal;Clinical and Translational Oncology;2023-12-08

5. Practicality of STAT3 Gene Polymorphisms and Sorafenib Trough Concentration as Biomarkers for Sorafenib-Induced Hand-Foot Skin Reaction in Hepatocellular Carcinoma;Journal of Clinical Pharmacy and Therapeutics;2023-08-19